Aegle Therapeutics Announces $4M Financing to Fund Groundbreaking Stem Cell Exosome Clinical Trial to Treat Orphan Disease Dystrophic Epidermolysis Bullosa

Jan 07, 2020

The investment led by Boca Raton-based New World Angels with participation from Tellus BioVentures will enable Aegle Therapeutics to advance development of their treatment for a rare pediatric skin blistering disorder…

Read more >